Bayer AG NA - Asset Resilience Ratio
Bayer AG NA (BAYN) has an Asset Resilience Ratio of 6.95% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2024)
This chart shows how Bayer AG NA's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Bayer AG NA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €5.90 Billion | 5.66% |
| Short-term Investments | €1.34 Billion | 1.29% |
| Total Liquid Assets | €7.24 Billion | 6.95% |
Asset Resilience Insights
- Limited Liquidity: Bayer AG NA maintains only 6.95% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Bayer AG NA Industry Peers by Asset Resilience Ratio
Compare Bayer AG NA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
AstraZeneca PLC
NASDAQ:AZN |
Drug Manufacturers - General | 5.03% |
|
Pfizer Inc
NYSE:PFE |
Drug Manufacturers - General | 7.18% |
|
Novartis AG
SW:NOVN |
Drug Manufacturers - General | 10.04% |
|
Zhejiang Int'L Group Co Ltd
SHE:000411 |
Drug Manufacturers - General | 0.00% |
|
Zhejiang Zhenyuan Share Co Ltd
SHE:000705 |
Drug Manufacturers - General | 5.75% |
|
Hunan Jingfeng Pharmaceutical
SHE:000908 |
Drug Manufacturers - General | 0.38% |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952 |
Drug Manufacturers - General | 5.37% |
|
Zhejiang Haisen Pharmaceutical Co. Ltd. A
SHE:001367 |
Drug Manufacturers - General | 32.14% |
Annual Asset Resilience Ratio for Bayer AG NA (2000–2024)
The table below shows the annual Asset Resilience Ratio data for Bayer AG NA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 7.30% | €8.09 Billion | €110.85 Billion | -1.81pp |
| 2023-12-31 | 9.11% | €10.59 Billion | €116.26 Billion | +0.98pp |
| 2022-12-31 | 8.13% | €10.15 Billion | €124.88 Billion | +1.69pp |
| 2021-12-31 | 6.44% | €7.74 Billion | €120.24 Billion | -3.72pp |
| 2020-12-31 | 10.15% | €11.88 Billion | €117.05 Billion | +5.87pp |
| 2019-12-31 | 4.28% | €5.40 Billion | €126.26 Billion | +0.85pp |
| 2018-12-31 | 3.43% | €4.34 Billion | €126.28 Billion | -8.68pp |
| 2017-12-31 | 12.12% | €9.10 Billion | €75.09 Billion | +5.52pp |
| 2016-12-31 | 6.60% | €5.42 Billion | €82.24 Billion | +6.23pp |
| 2015-12-31 | 0.37% | €272.00 Million | €73.92 Billion | +0.15pp |
| 2014-12-31 | 0.22% | €154.00 Million | €70.23 Billion | -0.05pp |
| 2013-12-31 | 0.27% | €138.00 Million | €51.32 Billion | -0.39pp |
| 2012-12-31 | 0.66% | €339.00 Million | €51.34 Billion | -4.62pp |
| 2011-12-31 | 5.28% | €2.78 Billion | €52.77 Billion | +3.32pp |
| 2010-12-31 | 1.96% | €1.01 Billion | €51.51 Billion | +1.24pp |
| 2009-12-31 | 0.72% | €367.00 Million | €51.04 Billion | -0.49pp |
| 2008-12-31 | 1.21% | €634.00 Million | €52.51 Billion | +0.56pp |
| 2007-12-31 | 0.65% | €335.00 Million | €51.38 Billion | +0.53pp |
| 2006-12-31 | 0.12% | €69.71 Million | €55.89 Billion | -0.51pp |
| 2005-12-31 | 0.64% | €233.03 Million | €36.69 Billion | +0.56pp |
| 2004-12-31 | 0.08% | €28.77 Million | €37.78 Billion | -0.27pp |
| 2003-12-31 | 0.34% | €128.63 Million | €37.38 Billion | +0.28pp |
| 2002-12-31 | 0.07% | €28.59 Million | €41.73 Billion | -0.07pp |
| 2001-12-31 | 0.14% | €51.70 Million | €37.10 Billion | -0.45pp |
| 2000-12-31 | 0.59% | €214.01 Million | €36.55 Billion | -- |
About Bayer AG NA
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast age… Read more